Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 19735649)

  • 1. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
    Chiu SJ; Lee YJ; Hsu TS; Chen WS
    Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells.
    Chiu SJ; Chao JI; Lee YJ; Hsu TS
    Toxicol Lett; 2008 Jun; 179(2):63-70. PubMed ID: 18499365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
    McVean M; Weinberg WC; Pelling JC
    Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.
    Hata T; Yamamoto H; Ngan CY; Koi M; Takagi A; Damdinsuren B; Yasui M; Fujie Y; Matsuzaki T; Hemmi H; Xu X; Kitani K; Seki Y; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Mol Cancer Ther; 2005 Oct; 4(10):1585-94. PubMed ID: 16227409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) exhibits p53-dependent and -independent antiproliferative activity in human nasopharyngeal carcinoma cells in vitro and in vivo.
    Nguyen TH; Ong CK; Wong E; Leong CT; Panasci L; Huynh H
    Int J Oncol; 2005 Oct; 27(4):1131-40. PubMed ID: 16142332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference of cell cycle arrests induced by lidamycin in human breast cancer cells.
    Liu X; He H; Feng Y; Zhang M; Ren K; Shao R
    Anticancer Drugs; 2006 Feb; 17(2):173-9. PubMed ID: 16428935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells.
    Vondálová Blanářová O; Jelínková I; Hyršlová Vaculová A; Sova P; Hofmanová J; Kozubík A
    Cell Prolif; 2013 Dec; 46(6):665-76. PubMed ID: 24118195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines.
    Atallah D; Marsaud V; Radanyi C; Kornprobst M; Rouzier R; Elias D; Renoir JM
    Int J Hyperthermia; 2004 Jun; 20(4):405-19. PubMed ID: 15204521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells.
    Chiu SJ; Hsu TS; Chao JI
    Toxicol Lett; 2006 Dec; 167(2):122-30. PubMed ID: 17045763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA.
    Jaiswal AS; Multani AS; Pathak S; Narayan S
    Mol Cancer; 2004 Jan; 3():3. PubMed ID: 14728717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
    Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
    J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status.
    Magrini R; Bhonde MR; Hanski ML; Notter M; Scherübl H; Boland CR; Zeitz M; Hanski C
    Int J Cancer; 2002 Sep; 101(1):23-31. PubMed ID: 12209584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
    Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.
    Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
    Mol Cancer Ther; 2004 Feb; 3(2):169-78. PubMed ID: 14985457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells.
    Winters ZE; Ongkeko WM; Harris AL; Norbury CJ
    Oncogene; 1998 Aug; 17(6):673-84. PubMed ID: 9715268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells.
    Kalimutho M; Minutolo A; Grelli S; Federici G; Bernardini S
    Acta Pharmacol Sin; 2011 Nov; 32(11):1387-96. PubMed ID: 21927014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
    Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
    Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.